Page results
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
The department undertakes specialist dental treatment for those under 16 years of age ( 15 years and 11 months), and deals with the aetiology, prevention, diagnosis and treatment of oral disorders; mouth conditions and teeth of children.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding
-
Hepatitis B information for users of the RESPOND refugee health service.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG and topotecan (MATIN) treatment.
-
Macmillan Support and Information Service offer emotional support, advice and information to people affected by cancer and blood conditions.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to a part of the brain. This page breaks down the side effects your child may experience during and after treatment, and how best to cope with them.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
This information explains radium-223 therapy treat available at University College Hospital.
-
The fertility laboratory provides three main services. Semen analysis to test fertility, storage of semen samples and processing of semen samples for IUI treatments.
File results
-
FOI/2023/0614 - Communications
-
FOI/2023/0594 - Asthma Treatment
-
NIHR Patient Research Experience Survey 2022-2023
-
Neuroimmunology and CSF Laboratory User Handbook
-
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
-
FOI/2023/0449 - Endometriosis pathway
-
FOI/2023/0448 - Gender, transgender, non-binary guidance/ policy for staff and patients
-
FOI/2023/0422 - Renal cell treatment for carcinoma and melanoma
-
FOI/2023/0429 - Breast cancer treatment/ systemic anti-cancer therapies
-
FOI/2023/0426 - Maternity services staffing levels